To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids

Clinical trial NCT03371667 · UNKNOWN

Trial details

NCT number: NCT03371667
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Allogeneic Disease GVH - Graft Versus Host Reaction GVHD, Acute Stem Cell Transplant Complications

Start date: 2018-08-16
Primary completion: 2024-12-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.